Peregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board of Directors of Peregrine and Avid Bioservices
October 19, 2017 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company focused on helping improve patient lives by providing high quality biologics...
Avid Bioservices to Exhibit at 2017 BioProcess International Conference & Exhibition
September 19, 2017 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), today announced that the company...
Avid Bioservices to Exhibit at The Bioprocessing Summit 2017
August 16, 2017 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), today announced that the company...
Repligen Reports Second Quarter 2017 Financial Results
August 03, 2017 07:30 ET
|
Repligen Corporation
Record quarterly revenue of $32.5 millionFirst half 2017 revenue growth of 16% or 18% at constant currencyEnters agreement to acquire Spectrum, Inc., which closed August 1Prices follow-on offering...
Repligen Reports First Quarter 2017 Financial Results
May 04, 2017 07:30 ET
|
Repligen Corporation
Record quarterly revenue of $30.6 million reflects 22% year-over-year growth or 24% at constant currencyCompany increases net income and EPS guidance WALTHAM, Mass., May 04, 2017 (GLOBE NEWSWIRE)...
Peregrine to Report Financial Results for Second Quarter of Fiscal Year 2017 After Market Close on December 12, 2016
December 05, 2016 16:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company committed to improving patient lives by manufacturing...
Cell Line Selection Predicted to Shift to CMOs, Double Digit Increase in Demand for the Service
October 12, 2016 11:41 ET
|
Industry Standard Research
CARY, NC--(Marketwired - October 12, 2016) - A new report from Industry Standard Research (ISR), Bioprocessing Services and Technologies Market Trends and Outsourcing Dynamics, offers an in-depth look...
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2017 and Recent Developments
September 08, 2016 16:05 ET
|
Peregrine Pharmaceuticals Inc.
--SUNRISE Top-line Data Accepted for Late-Breaking Oral Presentation at European Society of Medical Oncology Congress in October 2016 -- -- Avid First Quarter Revenue of $5.6 Million with Over $20...
Avid Bioservices to Participate in Cambridge Healthtech Institute’s (CHI) 8th Annual The Bioprocessing Summit
August 09, 2016 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), today announced that the...
BMS and Biogen to Give Biomanufacturing Keynote Presentations at CHI's Eighth Annual The Bioprocessing Summit
June 21, 2016 13:45 ET
|
Cambridge Healthtech Institute
NEEDHAM, MA--(Marketwired - June 21, 2016) - Cambridge Healthtech Institute, a division of Cambridge Innovation Institute, is pleased to release the plenary session details for the eighth annual The...